Trademark: CENTRE FOR CANCER BIOLOGY 1389926
Word
CENTRE FOR CANCER BIOLOGY
Device Descrption:
INTERSECTING STRIPES DIVIDE DISC
ID
1389926
Trademark Type
Figurative
Status
Lapsed: Not accepted
Application Date
21 October 2010

Service
A.P.T. Patent and Trade Mark Attorneys

Goods and Services:
Class 44:
Medical services, including diagnostics and pathology services; pathology services, including pathology testing of human and animal specimens; provision of medical treatment including cancer treatment; analysis of pathology results; generation of pathology reports; health care consultancy services (medical); advisory services in relation to medical services; health care; medical assistance; medical clinics; veterinary services; dental services; radiology services, including X-ray, ultrasound mammography, CT and dental X-ray services, and including the analysis of results and the generation of reports; dissemination (being the provision) of information relating to medicine, diagnostic and pathology practice, clinical practice, health and health care, medical problems, pharmaceutical products, nutrition, medical services, chiropody, chiropractic services, healthcare, skincare, surgery, dentistry, drug and alcohol addiction clinics, fitness testing, genetic testing, health resort services, health risk assessments, health screening, hearing aid services, hearing testing, hospice services, medical advisory services, hypnotherapy, medical diagnosis, monitoring of patients, nursing, nutritional consultancy, ophthalmological services, optometry, osteopathy, paramedical services, pathology services, pharmacist services, physical therapy services, physician services, physiotherapy services, plastic surgery, podiatry, pregnancy testing, psychology services, hospital services, dietetic advice, behavioural modification, vaccination, medical assistance, medical facilities, nursing care, psychiatric services, and rehabilitation services; medical information and medical services, including specimen and other data collection, testing, analysis, and reporting services relating to drug and alcohol testing; pathology services, including the pathology testing of human and animal specimens; analysis of pathology results; generation of pathology reports; histopathology services; medical and health care services including the provision of diagnostic, imaging, pathology, general practitioner and related services; medical and diagnostic services, namely, diagnosing, preventing, and predicting disease, indentifying hereditary risk factors, diagnostic testing, prognostic testing, gene and protein testing, identifying physiological characteristics, establishing disease treatment based on gene and protein expression and/or activity, evaluating clinical trial progress, drug monitoring and monitoring of a patient's health progress; production of antibodies, including monoclonal antibodies for medical purposes; generation of tissue cell lines, including hybridoma cell lines for medical purposes; disease advisory services